06.04.20

Bausch + Lomb Receives FDA Clearance for Infuse Daily Disposable Silicone Hydrogel Contact Lenses

Source: Bausch + Lomb

05.27.20

Bausch + Lomb Announces European Launch of a New Platform of Preloaded IOLs, LuxSmart and LuxGood

Source: Bausch + Lomb

05.06.20

Bausch + Lomb Licenses Exclusive Rights To a Biosimilar Candidate for Lucentis (Ranibizumab) in the US and Canada

Source: Bausch + Lomb

04.28.20

Clearside Biomedical Revises NDA Resubmission Timeline and Xipere Commercial Partnership with Bausch Health

Source: Clearside Biomedical

04.14.20

Bausch + Lomb Announces Publication Of 10-Year Armor Study Results On Ocular Antibiotic Resistance

Source: Bausch + Lomb

03.25.20

Bausch Health Donates Health Care Products And Supplies In Response To COVID-19 Pandemic

Source: Bausch Health

03.09.20

Nicox’s Partner Secures Additional Approval of Vyzulta in Taiwan

Source: Nicox

01.28.20

Bausch + Lomb and TerraCycle Partner to Launch Canada’s First and Only Contact Lens Recycling Program

Source: Bausch + Lomb

01.16.20

Bausch + Lomb Secures Additional Approvals of Vyzulta in Hong Kong and Argentina

Source: Nicox

01.13.20

Bausch + Lomb Secures Approval of Vyzulta in Mexico

Source: Nicox

View more stories